1 year return (CAGR)
22.75%
Genmab AS Exchange (NASDAQ, USD)
GMAB
34.15
+1.50 (+4.59%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-3.32%
5 year return (CAGR)
-6.21%
10 year return (CAGR)
7.92%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
20.99B
Price/Sales
5.08
Ent value
26.04B
Price/Book
3.52
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
26.63
PEG
-
Forward P/E
21.48
EPS growth
6.29%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 32.35 |
| Daily high | 34.19 |
| Daily low | 32.34 |
| Daily Volume | 3.09M |
| All-time high | 48.72 |
| 1y analyst estimate | 38.84 |
| Beta | 0.69 |
| EPS (TTM) | 1.28 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 17 Feb 2026 |
Downside potential
Loading...
Downside potential data
| GMAB | S&P500 | |
| Current price drop from All-time high | -29.91% | -2.63% |
| Highest price drop | -84.20% | -56.47% |
| Date of highest drop | 8 Aug 2011 | 9 Mar 2009 |
| Avg drop from high | -22.03% | -10.68% |
| Avg time to new high | 21 days | 12 days |
| Max time to new high | 1262 days | 1805 days |
News
